Cargando…
4528 Sirtuin 3 activation as a potential renoprotective therapy in a mouse model of Alport syndrome
OBJECTIVES/GOALS: Sirtuin 3 (Sirt3), a mitochondrial NAD(+)-dependent deacetylase, is decreased in diverse models of kidney disease, and Sirt3 activation prevents disease progression in many of those models. We are investigating if pharmacological activation of Sirt3 ameliorates kidney disease in a...
Autores principales: | Jones, Bryce, Myakala, Komuraiah, Wang, Xiaoxin, Libby, Andrew, Takahashi, Shogo, Bhasin, Kanchan, Ranjit, Suman, Rosenberg, Avi, Levi, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822961/ http://dx.doi.org/10.1017/cts.2020.91 |
Ejemplares similares
-
27558 Obeticholic acid (OCALIVA ®) protects against 2,8-dihydroxyadenine nephropathy in mice
por: Jones, Bryce, et al.
Publicado: (2021) -
Fibrosis quantification using multiphoton excitation imaging of picrosirius red stained cardiac tissue
por: Jones, Bryce A., et al.
Publicado: (2023) -
SRGAP2a: A New Player That Modulates Podocyte Cytoskeleton and Injury in Diabetes
por: Levi, Moshe, et al.
Publicado: (2018) -
The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice
por: Wang, Xiaoxin X., et al.
Publicado: (2022) -
Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice
por: Kurtz, Ryan, et al.
Publicado: (2022)